ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.641,30
0,25%
S&P 500
5.477,90
0,16%
US Dollar vs BRL
5,5168
1,18%
Bitcoin
60.819,60
-1,60%
Brent Oil
84,415
0,27%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Bicycle Therapeutics PLC (BCYC)

  7. Bicycle Therapeutics PLC (BCYC) Notícias

BCYC

Bicycle Therapeutics (BCYC)

Bicycle Therapeutics PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BCYC
DataHoraFonteTítuloCódigoCompanhia
18/06/202417:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCYCBicycle Therapeutics PLC
18/06/202417:14Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:BCYCBicycle Therapeutics PLC
03/06/202408:00Business WireBicycle Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BCYCBicycle Therapeutics PLC
23/05/202418:05Business WireBicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual MeetingNASDAQ:BCYCBicycle Therapeutics PLC
23/05/202408:00Business WireBicycle Therapeutics Announces $555 Million Private Placement Equity FinancingNASDAQ:BCYCBicycle Therapeutics PLC
02/05/202408:00Business WireBicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial ResultsNASDAQ:BCYCBicycle Therapeutics PLC
24/04/202411:05Business WireBicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual MeetingNASDAQ:BCYCBicycle Therapeutics PLC
02/04/202408:00Business WireBicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:BCYCBicycle Therapeutics PLC
05/03/202418:35Business WireBicycle Therapeutics to Present at the AACR Annual Meeting 2024NASDAQ:BCYCBicycle Therapeutics PLC
21/02/202418:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
21/02/202418:40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
20/02/202410:38Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BCYCBicycle Therapeutics PLC
20/02/202409:19Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BCYCBicycle Therapeutics PLC
20/02/202409:05Business WireBicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BCYCBicycle Therapeutics PLC
14/02/202418:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BCYCBicycle Therapeutics PLC
07/02/202409:00Business WireBicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:BCYCBicycle Therapeutics PLC
03/01/202418:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
14/12/202309:00Business WireBicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D DayNASDAQ:BCYCBicycle Therapeutics PLC
30/11/202309:00Business WireBicycle Therapeutics to Host R&D Day on December 14NASDAQ:BCYCBicycle Therapeutics PLC
02/11/202308:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCYCBicycle Therapeutics PLC
02/11/202308:00Business WireBicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D DayNASDAQ:BCYCBicycle Therapeutics PLC
19/10/202308:00Business WireBicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder CancerNASDAQ:BCYCBicycle Therapeutics PLC
19/10/202305:00GlobeNewswire Inc.Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive DirectorNASDAQ:BCYCBicycle Therapeutics PLC
11/09/202312:08Dow Jones NewsBicycle Therapeutics Shares Rise 8% After Continuation of BT8009 DevelopmentNASDAQ:BCYCBicycle Therapeutics PLC
11/09/202308:00Business WireBicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder CancerNASDAQ:BCYCBicycle Therapeutics PLC
05/09/202308:00Business WireBicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:BCYCBicycle Therapeutics PLC
03/08/202307:59Business WireBicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:BCYCBicycle Therapeutics PLC
18/07/202308:00Business WireBicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:BCYCBicycle Therapeutics PLC
13/07/202317:17Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCYCBicycle Therapeutics PLC
12/07/202323:23Business WireBicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary SharesNASDAQ:BCYCBicycle Therapeutics PLC
 Apresentando as notícias mais relevantes sobre:NASDAQ:BCYC

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
AZEV4
AZEVEDO PN
BOV
HAGA3
HAGA ON
BOV
GFSA3
GAFISA ON
BOV
COGN3
COGNA ON
BOV
JFEN3
JOAO FORTES ON
BOV
PRIO3
PETRORIO ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
INEP4
INEPAR PN
BOV
FNAM11
Fundo Invest Amazonia Fi...
BOV
GOLL4
GOL PN
BOV
RNEW4
RENOVA PN
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
RCSL4
RECRUSUL PN
BOV
LUPA3
LUPATECH ON
BOV
ETER3
ETERNIT ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados